If your mother was diagnosed with breast cancer at 45, the age matters as much as the diagnosis. A close relative affected at a young age is one of the specific patterns that clinical guidelines treat as a reason to look more carefully at the rest of the family history. It does not mean you will get the same cancer, and it does not translate into a personal risk percentage. What it does is justify a conversation with a clinician about whether earlier screening or genetic testing is worth considering in your case.
This guide explains why the age at diagnosis carries weight, what raises or lowers the level of concern, and what to gather before you raise it with a doctor.
Why does a young age at diagnosis matter?
Most breast cancers are diagnosed later in life and are not driven by an inherited variant. A cancer that appears unusually young is more likely to involve a hereditary cancer syndrome than the same cancer in old age, so guidelines weight it differently. The U.S. Preventive Services Task Force (USPSTF) recommends (a Grade B recommendation, 2019) that primary-care clinicians use a validated questionnaire to identify women whose family history is associated with an increased chance of a BRCA1 or BRCA2 variant, and refer those who screen positive for genetic counseling. A first-degree relative — a mother, sister, or daughter — diagnosed before 50 is one of the histories those tools are built to catch.
Across a range of conditions, having a close relative affected is associated with about 2 to 5 times the population-level risk, and that figure rises with the number of affected relatives. That is a population average drawn from many families, not your number. A clinician’s job is to turn your specific history into an assessment; an app’s job is to make sure that history is complete before they see it.
What raises or lowers the level of concern?
A single relative’s diagnosis sits on a spectrum. The features below push a family history toward “worth a closer look,” and a counselor or doctor weighs them together rather than one at a time.
| Feature | Why it raises concern |
|---|---|
| A young age at diagnosis (well under the usual age for that cancer) | The earlier the diagnosis, the more likely an inherited cause. A mother diagnosed at 45 carries more signal than the same cancer at 75. |
| More than one relative with the same or a related cancer | Breast and ovarian cancer cluster in the same syndromes. Two affected relatives on the same side weigh more than one. |
| Cancers on the same side of the family | Risk follows a lineage. A maternal grandmother and a mother carry more weight together than two relatives on opposite sides. |
| A known genetic variant already found in the family | If a relative has tested positive for a BRCA1, BRCA2, or other variant, testing you for that exact variant is faster and more definite. |
| Certain ancestries | Some inherited variants are more common in particular populations, which a counselor factors into the assessment. |
A history with none of these beyond the single diagnosis is a weaker signal, and a clinician may simply note it. The point of writing it all down is that you usually cannot tell which category you are in until the whole picture is on one page.
Does this give you a personal risk number?
No, and that limit is worth stating plainly. RHR does not generate a personal risk percentage, and neither USPSTF nor NCCN guidelines produce one from family history alone. Quantifying individual risk is a clinical assessment that uses validated tools, sometimes combined with genetic testing, and it belongs with a doctor or a genetic counselor. What family history does well is flag who should have that assessment. When a notable family history of cancer is taken into account, about 1 in 7 people were found to carry a clinically actionable genetic variant, versus about 1 in 47 at average risk — a sixfold difference. That is the kind of population signal that moves someone from “no further action” to “worth assessing,” which is the decision the history actually informs.
What should you do next?
The useful sequence is to assemble the history first, then take it to someone who can assess it.
- Write down the cancers in your family, by side and by age. For each affected relative, record the specific cancer and the age at diagnosis. “Breast cancer, age 45” carries information that “cancer, older” does not. Build it as a three-generation pedigree covering grandparents, parents, siblings, and children.
- Note who started the concern. The relative whose diagnosis prompted the question, the proband, anchors how a counselor reads the rest of the family.
- Track down any genetic test results already in the family. A known variant in a relative changes what testing you would even need.
- Bring it to your doctor or a genetic counselor. Ask whether your history meets the criteria for a formal risk assessment, earlier screening, or testing. The decision stays with them; the history is what lets them make it.
RHR is built for the first three steps. It organizes the family history as a pedigree and produces a summary you can hand to a clinician. The science behind family health history explains why a complete, dated three-generation record changes what a clinician can see.
Before you go
A mother diagnosed at 45 is a recognised reason for a closer look, not a verdict. Write the family history down with ages at diagnosis, find any genetic test results already in the family, and take it to a doctor or counselor who can tell you whether earlier screening or testing applies to you. The number that matters is not one an app can give you; it is the assessment that the written history makes possible.